Johnson & Johnson Announces New Head for Innovative Medicine Division

Jennifer Taubert, Executive Vice President and Worldwide Chairman of Innovative Medicine at Johnson & Johnson, is set to retire on September 1, 2026. Tom Cavanaugh will succeed her in this executive role. This leadership transition is significant for the company's pharmaceutical and medical technology segments.